The current version of the Tecniplast website doesn't match your region. Please visit your local website to find information and offerings specific to your country.
The current version of the Tecniplast website doesn't match your region. Please visit your local website to find information and offerings specific to your country.
A recent study published in Cells investigates the therapeutic potential of targeting astrocyte mitochondria in a mouse model of Alzheimer’s disease. The authors demonstrate that overexpression of the mitochondrial protein UCP4 in astrocytes restores several aspects of neuronal and network function, even when treatment is initiated after the onset of disease symptoms.
The study shows that UCP4 improves hippocampal and subicular network oscillations associated with memory processing, enhances neuronal excitability, and normalizes alterations in calcium and potassium signaling observed in Alzheimer’s disease mice. The researchers also found that UCP4 increases the production of glial cell line-derived neurotrophic factor (GDNF), suggesting a mechanism through which astrocytes can support neuronal resilience and function.
An important aspect of the article is the use of Tecniplast’s DVC® home-cage monitoring system to characterize behavioral alterations before treatment. Continuous, non-invasive monitoring revealed disruptions in circadian activity patterns and increased anxiety-like behavior in Alzheimer’s disease mice, demonstrating the sensitivity of home-cage monitoring technologies for detecting disease-related phenotypes.
Overall, the findings support astrocyte-targeted interventions as a promising avenue for neurodegenerative disease research and further highlight the value of DVC® technology for generating robust longitudinal behavioral data in preclinical studies
Find the paper
Corporate
Italia
Australia/New Zealand
France
Germany
Japan
USA
Canada
UK
China
Switzerland